Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan van Meerloo

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Hematology & Oncology|September 8, 2016
Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapyDenise Niewerth, Gertjan J L Kaspers, Gerrit Jansen, et al.
Haematologica|September 24, 2013
Higher ratio immune versus constitutive proteasome level as novel indicator of sensitivity of pediatric acute leukemia cells to proteasome inhibitorsDenise Niewerth, Niels E Franke, Gerrit Jansen, et al.
Molecular & Cellular Proteomics : MCP|February 28, 2020
Phosphotyrosine-based Phosphoproteomics for Target Identification and Drug Response Prediction in AML Cell LinesCarolien van Alphen, Jacqueline Cloos, Robin Beekhof, et al.
Journal of Cellular Physiology|January 22, 2020
Crizotinib sensitizes the erlotinib resistant HCC827GR5 cell line by influencing lysosomal functionNele Van Der Steen, Kaylee Keller, Henk Dekker, et al.
Molecular & Cellular Proteomics : MCP|January 24, 2016
Exosomes Secreted by Apoptosis-Resistant Acute Myeloid Leukemia (AML) Blasts Harbor Regulatory Network Proteins Potentially Involved in Antagonism of ApoptosisAnna Wojtuszkiewicz, Gerrit J Schuurhuis, Floortje L Kessler, et al.
Oncotarget|August 20, 2016
Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: a role for MARCKS in acquired resistance to proteasome inhibitorsNiels E Franke, Gertjan L Kaspers, Yehuda G Assaraf, et al.
Experimental Hematology & Oncology|January 12, 2013
Overcoming bortezomib resistance in human B cells by anti-CD20/rituximab-mediated complement-dependent cytotoxicity and epoxyketone-based irreversible proteasome inhibitorsSue Ellen Verbrugge, Marjon Al, Yehuda G Assaraf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2017
Monocytes and Granulocytes Reduce CD38 Expression Levels on Myeloma Cells in Patients Treated with DaratumumabJakub Krejcik, Kris A Frerichs, Inger S Nijhof, et al.
Eclinicalmedicine|June 20, 2023
Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort studyQuincy Hofsink, Sabine Haggenburg, Birgit I Lissenberg-Witte, et al.
Blood Advances|February 3, 2022
Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patientsSabine Haggenburg, Birgit I Lissenberg-Witte, Rob S van Binnendijk, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Hematology & Oncology|September 8, 2016
Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapyDenise Niewerth, Gertjan J L Kaspers, Gerrit Jansen, et al.
Haematologica|September 24, 2013
Higher ratio immune versus constitutive proteasome level as novel indicator of sensitivity of pediatric acute leukemia cells to proteasome inhibitorsDenise Niewerth, Niels E Franke, Gerrit Jansen, et al.
Molecular & Cellular Proteomics : MCP|February 28, 2020
Phosphotyrosine-based Phosphoproteomics for Target Identification and Drug Response Prediction in AML Cell LinesCarolien van Alphen, Jacqueline Cloos, Robin Beekhof, et al.
Journal of Cellular Physiology|January 22, 2020
Crizotinib sensitizes the erlotinib resistant HCC827GR5 cell line by influencing lysosomal functionNele Van Der Steen, Kaylee Keller, Henk Dekker, et al.
Molecular & Cellular Proteomics : MCP|January 24, 2016
Exosomes Secreted by Apoptosis-Resistant Acute Myeloid Leukemia (AML) Blasts Harbor Regulatory Network Proteins Potentially Involved in Antagonism of ApoptosisAnna Wojtuszkiewicz, Gerrit J Schuurhuis, Floortje L Kessler, et al.
Oncotarget|August 20, 2016
Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: a role for MARCKS in acquired resistance to proteasome inhibitorsNiels E Franke, Gertjan L Kaspers, Yehuda G Assaraf, et al.
Experimental Hematology & Oncology|January 12, 2013
Overcoming bortezomib resistance in human B cells by anti-CD20/rituximab-mediated complement-dependent cytotoxicity and epoxyketone-based irreversible proteasome inhibitorsSue Ellen Verbrugge, Marjon Al, Yehuda G Assaraf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2017
Monocytes and Granulocytes Reduce CD38 Expression Levels on Myeloma Cells in Patients Treated with DaratumumabJakub Krejcik, Kris A Frerichs, Inger S Nijhof, et al.
Eclinicalmedicine|June 20, 2023
Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort studyQuincy Hofsink, Sabine Haggenburg, Birgit I Lissenberg-Witte, et al.
Blood Advances|February 3, 2022
Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patientsSabine Haggenburg, Birgit I Lissenberg-Witte, Rob S van Binnendijk, et al.
Pageof 2